Antioxidant and physiological effects of Si-Wu-Tang on skin and liver: a randomized, double-blind, placebo-controlled clinical trial

Table 4 The lipid profile in plasma of placebo and SWT treated healthy subjects

Group	TG (mg/dL)	p value*	TC (mg/dL)	p value*	HDL-c (mg/dL)	p value*	LDL-c (mg/dL)	p value*
Baseline
Placebo	100.22 ± 25.60^a	0.81	192.85 ± 38.05^a	0.95	57.02 ± 11.21^a	0.87	114.98 ± 32.99^a	0.69
SWT	102.12 ± 28.60^a	0.81	192.05 ± 35.34^a	0.95	57.52 ± 10.25^b	0.87	113.05 ± 31.23^a	0.69
3rd month
Placebo	97.56 ± 14.96^a	0.01	191.71 ± 34.63^a	0.62	58.60 ± 12.88^a	0.45	113.60 ± 34.04^a	0.83
SWT	87.27 ± 14.64^b	0.01	192.20 ± 35.55^a	0.62	59.20 ± 13.41^a	0.45	113.13 ± 32.32^a
6th month
Placebo	97.64 ± 23.39^a	0.01	192.36 ± 32.85^a	0.88	57.51 ± 12.75^a	0.23	113.84 ± 32.21^a	0.48
SWT	85.89 ± 17.86^b	0.01	192.73 ± 36.25^a	0.88	59.13 ± 12.31^a	0.23	112.84 ± 33.68^a	0.48

Values were expressed as mean ± SD (n = 55). Data within the same column of each group bearing different superscript letters were significantly different (p < 0.05)
* Student’s t test was used to assess statistical significance between placebo and Si Wu Tang (SWT)

ISSN: 1749-8546